These can include weight loss, loss of appetite, yellowing of the skin, vomiting or nausea, and the symptoms of diabetes ...

The medicines regulator is investigating after hundreds of people have reported problems with their pancreas linked to taking ...

Since the GLP-1 drugs, including Mounjaro, Ozempic and Wegovy, were licensed, there have been hundreds of reported cases of ...

Weight loss jabs have recently gained a lot of popularity as they become more accessible to people through their general ...

UK health officials have launched a study into side-effects of weight loss drugs including Ozempic, Mounjaro and Wegovy ...

As the NHS rolls out Mounjaro being prescribed by GPs, weight loss jabs have been linked to potentially fatal side effects in new data ...

The UK is studying cases of pancreatitis in people taking drugs based on GLP-1 receptor agonists for weight loss or type 2 ...

Data show that since the drugs were licensed there have been hundreds of cases of acute and chronic pancreatitis ...

Patients have reported being hospitalised with inflammation of the pancreas suspected to be related to medicines such as ...

Hundreds of people have reported problems with their pancreas after taking GLP-1 agonists, including ten deaths.

The U.K. is asking patients whose pancreas became dangerously inflamed after taking obesity drugs like Wegovy and Zepbound to ...

The UK’s drug regulator is to study possible serious side effects of glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro). Data from ...